Breathless at 4,500 m: reading an arterial gas at altitude
A 24-year-old man who has lived all his life at sea level flies to Leh (3,500 m) and, without a rest day, drives the same evening to a camp at 4,500 m. Thirty-six hours later he has a throbbing bifrontal headache, nausea, breathlessness at rest and a dry cough. He is afebrile; pulse 108/min, respiratory rate 26/min, SpO2 82% breathing room air, chest clear on auscultation, no pedal oedema, no neck stiffness, and his gait is normal. He has drunk very little water since arrival and has taken acetazolamide 125 mg twice daily for two days. Arterial blood gas on room air: pH 7.50, PaCO2 28 mmHg, PaO2 42 mmHg, HCO3- 21 mmol/L. Chest radiograph shows patchy opacities in the right mid and lower zones. He is alert and oriented but anxious, and asks whether he can wait until morning to see a doctor, since the nearest hospital is a four-hour drive down.
1. Interpret the arterial blood gas. Explain the physiological reason why breathing faster cannot restore his PaO2 to normal at this altitude.
Read the worked answer
Acid–base and oxygenation
- pH 7.50 with PaCO2 28 mmHg and HCO3 21 mmol/L is an acute respiratory alkalosis with only partial renal compensation - the expected picture at 36 hours, because renal bicarbonate excretion takes 2–4 days.
- The alveolar gas equation sets the ceiling on PaO2: PAO2 = FiO2 (Pb − 47) − PaCO2/0.8. At about 4,500 m, barometric pressure is roughly 440 mmHg, so PIO2 is only ~83 mmHg. Even hyperventilating to a PaCO2 of 28 mmHg gives an ideal PAO2 of roughly 48 mmHg; a PaO2 of 42 mmHg therefore leaves an A–a gradient of about 6 mmHg, mildly widened and explained by the infiltrates rather than by hypoventilation alone.
Why faster breathing has a limit
- Hypocapnia blunts the central chemoreceptor drive. Peripheral chemoreceptor drive from hypoxia is strong but is offset by the alkalosis, so the gain flattens.
- The work of breathing itself consumes oxygen and generates CO2.
- Hypocapnia causes cerebral vasoconstriction - protective against oedema early, but a brake on further compensation.
- The leftward shift of the oxygen dissociation curve from alkalosis impairs tissue unloading.
- Periodic breathing and sleep hypoventilation lower the average ventilation over 24 hours. The infiltrates plus breathlessness at rest mean the widened gradient is not benign - this is the setting for HAPE.
2. Explain how 2,3-BPG and the oxygen–haemoglobin dissociation curve change during acclimatisation at 4,500 m, and state the net trade-off.
Read the worked answer
Two opposing shifts
- The respiratory alkalosis itself shifts the curve to the left within minutes (Bohr effect), which raises pulmonary loading but impairs unloading at the tissue - the opposite of what a hypoxic tissue needs.
- Over 24–48 hours, red cell 2,3-BPG rises (increased glycolytic flux in the red cell, favoured by the alkalotic intracellular pH). 2,3-BPG binds deoxyhaemoglobin and stabilises the T state, shifting the curve back to the right.
The trade-off A right-shifted curve improves oxygen extraction at a given tissue PO2, but at 4,500 m the arterial point sits on the steep part of the curve, so a right shift also lowers SaO2 for the same alveolar PO2. The net effect is usually judged favourable for tissue delivery because the limiting factor at altitude is unloading, not loading; the fall in saturation is modest compared with the gain in extraction. This is why 2,3-BPG is regarded as a genuine acclimatisation response rather than a maladaptation.
What it does not fix It does nothing for the underlying low PIO2, and it is not a treatment. It also explains why stored blood has a right-shifted curve which normalises within hours of transfusion, and why the same mechanism makes chronically anaemic and hypoxic patients different from healthy trekkers.
3. Does he have high-altitude pulmonary oedema? Justify your answer against recognised criteria and state the immediate management, including whether he can safely wait until morning.
Read the worked answer
Diagnosis - yes HAPE is diagnosed when a recent altitude gain is accompanied by at least two symptoms (dyspnoea at rest, cough, weakness, chest tightness) and at least two signs (crackles, central cyanosis, tachypnoea, tachycardia). He has dyspnoea at rest and cough, with tachypnoea at 26/min and tachycardia at 108/min; the radiograph supports it. Mild HACE is not excluded - headache and nausea alone do not establish it, and normal gait without ataxia argues against significant cerebral oedema.
Management
- Descent is definitive and should start now; a four-hour drive is acceptable if he is driven, kept warm and given oxygen en route.
- Supplemental oxygen to keep SpO2 above 90%, and a portable hyperbaric chamber if descent is delayed.
- Nifedipine 10–20 mg orally then slow release, or a phosphodiesterase-5 inhibitor, if descent is impossible.
- Acetazolamide is for prevention and for periodic breathing; it is not a treatment for HAPE.
- Avoid exertion, cold and further ascent.
Can he wait until morning? No. HAPE can progress to death within hours overnight, and deterioration while asleep at altitude is the classic pattern. The judgement call is to descend immediately rather than observe.